Please assess the completion status of the following clinical trial:

Trial Title: Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~- Women admitted to the Centre for Recurrent Pregnancy Loss of Western Denmark January 2016 to March 2020~Exclusion Criteria:~* Less than 3 consecutive pregnancy losses~* Significant uterine malformation on hydrosonography or hysteroscopy~* Significant chromosomal abnormalities~* Abnormal menstrual cycle length (\<22 or \>35 days) or irregular cycle~* Pregnancy at first meeting in the Recurrent Miscarriage Clinic~* Age \<18 and \>45 years

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Study sample (Type: None): In total, 267 women with unexplained recurrent pregnancy loss was included.~Only patients with a history of 3 or more consecutive spontaneous pregnancy losses are included. Both biochemical and clinical losses documented in hospital records are accepted. Verified extrauterine pregnancy losses, complete molar pregnancies, and induced abortions of social reasons are not included in the total number of pregnancy losses. Women are excluded from this study, if they have significant uterine malformations, significant parental chromosomal abnormalities, irregular and/or abnormal length of their menstrual cycle length (\<22 and \>35 days interval), and/or no MBL measurement.
- Reference Group (Type: None): The MBL reference group comprised 185 Danish female blood donors of reproductive age (range 21 to 45 years), about whom we have no other information. After informed approval, all controls had an extra blood sample taken, which was analysed for p-MBL.

Based on this trial design, predict the completion outcome and termination type (if applicable).